Citigroup’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-28,900
Closed -$3.87M 5733
2024
Q2
$3.87M Buy
+28,900
New +$5.47M ﹤0.01% 1826

Other funds holding INSP

Citigroup's INSP Position: Q2 2026 in Review

Citigroup increased its Inspire Medical Systems (INSP) stake by 146% in Q2 2026, buying an estimated $2.19M and bringing the position to 77,780 shares worth $3.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2464.

Citigroup first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $6.69M in Q2 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Citigroup held 77,780 shares of Inspire Medical Systems worth $3.47M as of Q2 2026.
  • Citigroup bought 46,174 Inspire Medical Systems shares in Q2 2026, an estimated $2.19M.
  • Inspire Medical Systems made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2464 holding.
  • Citigroup first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
  • Citigroup's Inspire Medical Systems position peaked at $6.69M in Q2 2025.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.